Medical Subject Headings

Last uploaded: November 5, 2019
Preferred Name

Neurofibromatosis 1

Synonyms

von Recklinghausen Disease

Definitions

An autosomal dominant inherited disorder (with a high frequency of spontaneous mutations) that features developmental changes in the nervous system, muscles, bones, and skin, most notably in tissue derived from the embryonic NEURAL CREST. Multiple hyperpigmented skin lesions and subcutaneous tumors are the hallmark of this disease. Peripheral and central nervous system neoplasms occur frequently, especially OPTIC NERVE GLIOMA and NEUROFIBROSARCOMA. NF1 is caused by mutations which inactivate the NF1 gene (GENES, NEUROFIBROMATOSIS 1) on chromosome 17q. The incidence of learning disabilities is also elevated in this condition. (From Adams et al., Principles of Neurology, 6th ed, pp1014-18) There is overlap of clinical features with NOONAN SYNDROME in a syndrome called neurofibromatosis-Noonan syndrome. Both the PTPN11 and NF1 gene products are involved in the SIGNAL TRANSDUCTION pathway of Ras (RAS PROTEINS).

ID

http://purl.bioontology.org/ontology/MESH/D009456

altLabel

von Recklinghausen Disease

Neurofibromatoses, Type I

Type I Neurofibromatoses

Recklinghausen's Disease of Nerve

Syndrome, Watson

Neurofibromatosis, Peripheral Type

Neurofibromatosis, Peripheral

Neurofibromatosis, Peripheral, NF1

Recklinghausen Disease, Nerve

Molluscum Fibrosum

Neurofibromatosis I

Neurofibromatosis Type 1

Recklinghausens Disease of Nerve

Recklinghausen Disease of Nerve

Peripheral Neurofibromatoses

Cafe au Lait Spots with Pulmonic Stenosis

Neurofibromatosis Type I

von Recklinghausen's Disease

Pulmonic Stenosis with Cafe-au-Lait Spots

Pulmonic Stenosis with Cafe au Lait Spots

Watson Syndrome

Neurofibromatosis, Type 1

von Recklinghausens Disease

Neurofibromatoses, Peripheral

Neurofibromatosis, Peripheral, NF 1

Type 1, Neurofibromatosis

Neurofibromatosis, Type I

NF1 (Neurofibromatosis 1)

Cafe-au-Lait Spots with Pulmonic Stenosis

Type I, Neurofibromatosis

Peripheral Neurofibromatosis

Type 1 Neurofibromatosis

AN

do not confuse with NEUROFIBROMATOSIS 2; coord IM with precoord organ/neopl term (IM) if relevant

AQL

BL CF CI CL CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI

cui

C0553586

C0027831

DC

1

definition

An autosomal dominant inherited disorder (with a high frequency of spontaneous mutations) that features developmental changes in the nervous system, muscles, bones, and skin, most notably in tissue derived from the embryonic NEURAL CREST. Multiple hyperpigmented skin lesions and subcutaneous tumors are the hallmark of this disease. Peripheral and central nervous system neoplasms occur frequently, especially OPTIC NERVE GLIOMA and NEUROFIBROSARCOMA. NF1 is caused by mutations which inactivate the NF1 gene (GENES, NEUROFIBROMATOSIS 1) on chromosome 17q. The incidence of learning disabilities is also elevated in this condition. (From Adams et al., Principles of Neurology, 6th ed, pp1014-18) There is overlap of clinical features with NOONAN SYNDROME in a syndrome called neurofibromatosis-Noonan syndrome. Both the PTPN11 and NF1 gene products are involved in the SIGNAL TRANSDUCTION pathway of Ras (RAS PROTEINS).

A syndrome characterized by the presence of PULMONARY STENOSIS; CAFE-AU-LAIT SPOTS; MENTAL RETARDATION; and short stature caused by mutations in the NF1 gene (GENES, NEUROFIBROMATOSIS 1).

DX

19920101

FX

D009634

D016514

D044542

D025542

HN

1992(1966); for NEUROFIBROMATOSIS, PERIPHERAL, NF1 use NEUROFIBROMATOSIS 1989-1991

Inverse of AQ

http://purl.bioontology.org/ontology/MESH/Q000401

http://purl.bioontology.org/ontology/MESH/Q000150

http://purl.bioontology.org/ontology/MESH/Q000188

http://purl.bioontology.org/ontology/MESH/Q000517

http://purl.bioontology.org/ontology/MESH/Q000201

http://purl.bioontology.org/ontology/MESH/Q000145

http://purl.bioontology.org/ontology/MESH/Q000503

http://purl.bioontology.org/ontology/MESH/Q000453

http://purl.bioontology.org/ontology/MESH/Q000208

http://purl.bioontology.org/ontology/MESH/Q000134

http://purl.bioontology.org/ontology/MESH/Q000821

http://purl.bioontology.org/ontology/MESH/Q000382

http://purl.bioontology.org/ontology/MESH/Q000601

http://purl.bioontology.org/ontology/MESH/Q000235

http://purl.bioontology.org/ontology/MESH/Q000523

http://purl.bioontology.org/ontology/MESH/Q000276

http://purl.bioontology.org/ontology/MESH/Q000191

http://purl.bioontology.org/ontology/MESH/Q000652

http://purl.bioontology.org/ontology/MESH/Q000662

http://purl.bioontology.org/ontology/MESH/Q000628

http://purl.bioontology.org/ontology/MESH/Q000196

http://purl.bioontology.org/ontology/MESH/Q000534

http://purl.bioontology.org/ontology/MESH/Q000266

http://purl.bioontology.org/ontology/MESH/Q000532

http://purl.bioontology.org/ontology/MESH/Q000139

http://purl.bioontology.org/ontology/MESH/Q000378

http://purl.bioontology.org/ontology/MESH/Q000175

http://purl.bioontology.org/ontology/MESH/Q000000981

http://purl.bioontology.org/ontology/MESH/Q000097

http://purl.bioontology.org/ontology/MESH/Q000473

http://purl.bioontology.org/ontology/MESH/Q000451

http://purl.bioontology.org/ontology/MESH/Q000209

http://purl.bioontology.org/ontology/MESH/Q000178

http://purl.bioontology.org/ontology/MESH/Q000469

Inverse of RO

http://purl.bioontology.org/ontology/MESH/D025542

http://purl.bioontology.org/ontology/MESH/D044542

http://purl.bioontology.org/ontology/MESH/D009634

http://purl.bioontology.org/ontology/MESH/D016514

Inverse of SIB

http://purl.bioontology.org/ontology/MESH/D011843

http://purl.bioontology.org/ontology/MESH/D059348

http://purl.bioontology.org/ontology/MESH/D053421

http://purl.bioontology.org/ontology/MESH/D020386

http://purl.bioontology.org/ontology/MESH/D016518

http://purl.bioontology.org/ontology/MESH/D000170

http://purl.bioontology.org/ontology/MESH/D000699

http://purl.bioontology.org/ontology/MESH/D056768

http://purl.bioontology.org/ontology/MESH/D017772

http://purl.bioontology.org/ontology/MESH/D020275

http://purl.bioontology.org/ontology/MESH/D020422

http://purl.bioontology.org/ontology/MESH/D020918

http://purl.bioontology.org/ontology/MESH/D010524

http://purl.bioontology.org/ontology/MESH/D009408

http://purl.bioontology.org/ontology/MESH/D052958

http://purl.bioontology.org/ontology/MESH/D009443

http://purl.bioontology.org/ontology/MESH/D003929

http://purl.bioontology.org/ontology/MESH/D011115

http://purl.bioontology.org/ontology/MESH/D020516

http://purl.bioontology.org/ontology/MESH/D009437

http://purl.bioontology.org/ontology/MESH/D000071075

Machine permutation

1992; see NEUROFIBROMATOSIS 1966-91; for NEUROFIBROMATOSIS, PERIPHERAL, NF1 see NEUROFIBROMATOSIS 1989-1991

MDA

19990101

MMR

20180629

MN

C10.668.829.675

C16.320.700.633.650

C10.574.500.549.400

C04.557.580.600.580.590.650

C04.700.631.650

C16.320.400.560.400

C10.562.600.500

notation

D009456

prefLabel

Neurofibromatosis 1

TERMUI

T028173

T371060

T371057

T371061

T028175

T431505

T028177

T841796

T028179

T028180

T769793

T371059

T371063

T371062

T028174

T842127

T028178

T811774

T028176

T769792

T371058

TH

NLM (2011)

UNK (19XX)

NLM (1992)

NLM (2002)

NLM (2000)

NLM (1966)

NLM (2014)

ORD (2010)

OMIM (2013)

GHR (2014)

tui

T191

T047

subClassOf

http://purl.bioontology.org/ontology/MESH/D017253

http://purl.bioontology.org/ontology/MESH/D010523

Delete Subject Author Type Created
No notes to display
Create New Mapping

Delete Mapping To Ontology Source
http://purl.obolibrary.org/obo/DOID_0111253 Human Disease Ontology 123 LOOM
http://purl.bioontology.org/ontology/OMIM/162200 Online Mendelian Inheritance in Man CUI
http://purl.bioontology.org/ontology/MEDLINEPLUS/C0027831 MedlinePlus Health Topics CUI
http://purl.bioontology.org/ontology/OMIM/193520 Online Mendelian Inheritance in Man CUI
http://purl.bioontology.org/ontology/OMIM/613113 Online Mendelian Inheritance in Man CUI
http://purl.bioontology.org/ontology/OMIM/613113 Online Mendelian Inheritance in Man CUI
http://purl.bioontology.org/ontology/ICD10CM/Q85.01 International Classification of Diseases, Version 10 - Clinical Modification CUI